Page last updated: 2024-10-29

ketanserin and Schizotypal Personality Disorder

ketanserin has been researched along with Schizotypal Personality Disorder in 1 studies

Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.

Schizotypal Personality Disorder: A personality disorder in which there are oddities of thought (magical thinking, paranoid ideation, suspiciousness), perception (illusions, depersonalization), speech (digressive, vague, overelaborate), and behavior (inappropriate affect in social interactions, frequently social isolation) that are not severe enough to characterize schizophrenia.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hurlemann, R1
Matusch, A1
Kuhn, KU1
Berning, J1
Elmenhorst, D1
Winz, O1
Kolsch, H1
Zilles, K1
Wagner, M1
Maier, W1
Bauer, A1

Other Studies

1 other study available for ketanserin and Schizotypal Personality Disorder

ArticleYear
5-HT2A receptor density is decreased in the at-risk mental state.
    Psychopharmacology, 2008, Volume: 195, Issue:4

    Topics: Adult; Brain; Brain Mapping; Cerebral Cortex; Dominance, Cerebral; Early Diagnosis; Female; Fluorine

2008